There are two main types: peptide vaccines, which contain tumor-associated or tumor-specific antigens (such as EGFRvIII or mutated IDH enzymes), and cell-based vaccines, such as dendritic cell (DC) vaccines. This evidence concerns the gene IDH1 and neoplasm.